Largest health care pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 health care pharmaceutical companies ranked by total assets, at NOK 2.03T, ahead of Johnson & Johnson (NOK 1.95T) and Sanofi (NOK 1.37T). Figures as of 19 Nov 2026, 23:07 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerNOK 2.03T
- Median
- NOK 34.4B
- Combined market value
- NOK 48.46T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | NOK 2.03T | NOK 1.53T | NOK 268.96 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | NOK 1.95T | NOK 6.28T | NOK 2,608.92 | 2.04% down | 34% up | ||
| 3 | SanofiSNY · Health Care | NOK 1.37T | NOK 1.08T | NOK 449.83 | 2.25% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | NOK 1.34T | NOK 3.2T | NOK 1,297.04 | 3.61% down | 45% up | ||
| 5 | AbbVieABBV · Health Care | NOK 1.31T | NOK 4.89T | NOK 2,769.09 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | NOK 1.11T | NOK 2.66T | NOK 1,713.08 | 1.87% down | 1% up | ||
| 7 | Eli LillyLLY · Health Care | NOK 1.1T | NOK 11.75T | NOK 13,195.21 | 2.29% down | 33% up | ||
| 8 | NovartisNVS · Health Care | NOK 1.08T | NOK 2.79T | NOK 1,476.83 | 2.57% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | NOK 948.7B | NOK 668B | NOK 209.09 | 0.66% up | 51% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | NOK 879.3B | NOK 1.16T | NOK 569.76 | 2.05% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | NOK 846.9B | NOK 1.76T | NOK 1,014.41 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | NOK 792.3B | NOK 936.1B | NOK 467.02 | 1.56% down | 5% up | ||
| 13 | Novo NordiskNVO · Health Care | NOK 786.8B | NOK 1.67T | NOK 379.61 | 1.42% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 398B | NOK 439.2B | NOK 376.39 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | NOK 396.1B | NOK 932.8B | NOK 9,017.46 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | NOK 363.2B | NOK 222.6B | NOK 194.15 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | NOK 250.4B | NOK 1.29T | NOK 5,084.83 | 2.94% down | 27% up | ||
| 18 | GrifolsGRFS · Health Care | NOK 213.6B | NOK 54.5B | NOK 80.08 | 3.19% down | 0% up | ||
| 19 | Royalty PharmaRPRX · Health Care | NOK 191.6B | NOK 380.3B | NOK 661.36 | 1.38% down | 79% up | ||
| 20 | ZoetisZTS · Health Care | NOK 151.1B | NOK 320.6B | NOK 789.01 | 5.59% down | 26% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | NOK 130.5B | NOK 128.3B | NOK 256.75 | 1.54% down | 26% up | ||
| 22 | GenmabGMAB · Health Care | NOK 125.7B | NOK 309.2B | NOK 501.49 | 0.75% up | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 113.9B | NOK 148.2B | NOK 2,309.20 | 4.57% down | 41% up | ||
| 24 | BeOne MedicinesONC · Health Care | NOK 80B | NOK 445.9B | NOK 3,903.52 | 0.97% down | 16% up | ||
| 25 | United TherapeuticsUTHR · Health Care | NOK 77B | NOK 232.5B | NOK 5,460.24 | 3.16% down | 22% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | NOK 74.2B | NOK 116.2B | NOK 599.84 | 0.02% down | 17% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 60.2B | NOK 120.7B | NOK 144.83 | 1.00% down | 8% up | ||
| 28 | Roivant SciencesROIV · Health Care | NOK 55.8B | NOK 275.7B | NOK 380.49 | 0.59% up | 91% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | NOK 48.5B | NOK 193.4B | NOK 1,443.63 | 1.06% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | NOK 35.9B | NOK 72.8B | NOK 208.90 | 2.24% down | 90% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | NOK 34.4B | NOK 44.3B | NOK 265.83 | 0.62% down | 63% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | NOK 28.3B | NOK 47.6B | NOK 569.61 | 3.16% down | 21% down | ||
| 33 | AlkermesALKS · Health Care | NOK 24.3B | NOK 75.8B | NOK 451.00 | 1.43% down | 66% up | ||
| 34 | InsmedINSM · Health Care | NOK 22.1B | NOK 309.5B | NOK 1,410.82 | 20.58% up | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | NOK 16.9B | NOK 30.5B | NOK 157.23 | 0.92% down | 41% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | NOK 15.2B | NOK 56.1B | NOK 2,802.29 | 3.94% down | 50% up | ||
| 37 | Ascendis PharmaASND · Health Care | NOK 14.1B | NOK 164B | NOK 2,499.74 | 5.32% down | 29% up | ||
| 38 | CytokineticsCYTK · Health Care | NOK 13.9B | NOK 70B | NOK 502.57 | 0.27% up | 19% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 13.5B | NOK 60.3B | NOK 426.29 | 1.25% up | 13% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 12.3B | NOK 90B | NOK 3,874.61 | 0.34% down | 27% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | NOK 10.4B | NOK 95.8B | NOK 633.63 | 1.88% down | 117% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | NOK 9.2B | NOK 84.9B | NOK 3,036.29 | 1.87% up | 86% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | NOK 9.2B | NOK 47.1B | NOK 270.91 | 0.25% down | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | NOK 9.1B | NOK 148.7B | NOK 763.52 | 0.22% up | 21% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | NOK 8.2B | NOK 60.9B | NOK 932.76 | 3.27% up | 34% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | NOK 8.2B | NOK 69.5B | NOK 634.60 | 4.15% down | 10% down | ||
| 47 | Belite BioBLTE · Health Care | NOK 7.6B | NOK 59.9B | NOK 1,474.88 | 3.33% down | 43% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | NOK 7.6B | NOK 90.6B | NOK 953.47 | 3.77% down | 332% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 7.5B | NOK 71.8B | NOK 913.47 | 1.59% down | 129% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | NOK 7.3B | NOK 82.6B | NOK 103.23 | 0.67% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | NOK 6.7B | NOK 69.7B | NOK 1,325.07 | 1.25% up | 6% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | NOK 6.5B | NOK 79.1B | NOK 1,211.20 | 2.47% down | 51% up | ||
| 53 | ABIVAXABVX · Health Care | NOK 6.3B | NOK 69B | NOK 787.64 | 3.79% down | 32% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | NOK 5.9B | NOK 45.3B | NOK 471.70 | 3.86% down | 45% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.4B | NOK 44B | NOK 402.07 | 0.48% down | 86% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | NOK 5.2B | NOK 46.7B | NOK 828.46 | 1.01% up | 108% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | NOK 4.8B | NOK 64.6B | NOK 952.88 | 1.91% up | 255% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 4.7B | NOK 79.1B | NOK 1,140.68 | 1.88% down | 18% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | NOK 4.3B | NOK 39.4B | NOK 287.91 | 1.24% up | 168% up | ||
| 60 | ErascaERAS · Health Care | NOK 3.9B | NOK 48.7B | NOK 138.87 | 3.34% up | 395% up | ||
| 61 | VeradermicsMANE · Health Care | NOK 1.5B | NOK 51.3B | NOK 1,214.81 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7661 NOK).
Questions and answers
Which health care pharmaceutical companies rank first by total assets?
Pfizer (NOK 2.03T), Johnson & Johnson (NOK 1.95T) and Sanofi (NOK 1.37T) are the top three of the 61 health care pharmaceutical companies ranked by total assets as of 19 Nov 2026, 23:07 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total assets have a combined market value of NOK 48.46T as of 19 Nov 2026, 23:07 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.